aluates Reports

$ 0.0

Automative

Global Inhalational Isoflurane Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-1H18063

BUY CHAPTERS

Global Inhalational Isoflurane Market Research Report 2024

Code: QYRE-Auto-1H18063

Report

August 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

KALBE PHARMA

Baxter

Neon Laboratories

AbbVie

Piramal

LAB UNKNOWN

Viatris

PT Novell Pharmaceutical

Sedana Medical

Lunan Beite

Inhalational Isoflurane Market Size

The global Inhalational Isoflurane market was valued at US$ 19 million in 2023 and is anticipated to reach US$ 26.8 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.

Inhalational Isoflurane Market

Isoflurane is a widely used inhalational anesthetic agent employed in general anesthesia. It is a halogenated ether with the chemical formula C₃H₂ClF₅O, and it functions by inducing a reversible loss of consciousness and sensation in patients undergoing surgical procedures. Isoflurane acts on the central nervous system by enhancing the inhibitory effects of neurotransmitters and disrupting neural pathways that mediate awareness and sensation. It is favored in clinical settings due to its stable cardiovascular effects, ease of control, and minimal metabolism by the liver. Its administration requires specialized equipment to ensure accurate delivery and maintenance of the desired anesthetic depth.

North American market for Inhalational Isoflurane is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Inhalational Isoflurane is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Inhalational Isoflurane include KALBE PHARMA, Baxter, Neon Laboratories, AbbVie, Piramal, LAB UNKNOWN, Viatris, PT Novell Pharmaceutical, Sedana Medical, Lunan Beite, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhalational Isoflurane, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalational Isoflurane.

The Inhalational Isoflurane market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Inhalational Isoflurane market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inhalational Isoflurane manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inhalational Isoflurane Market Report

Report Metric	Details
Report Name	Inhalational Isoflurane Market
Accounted market size in 2023	US$ 19 million
Forecasted market size in 2030	US$ 26.8 million
CAGR	4.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Generic Drugs Brand Drug
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	KALBE PHARMA, Baxter, Neon Laboratories, AbbVie, Piramal, LAB UNKNOWN, Viatris, PT Novell Pharmaceutical, Sedana Medical, Lunan Beite
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalational Isoflurane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalational Isoflurane in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Inhalational Isoflurane Market growing?

Ans: The Inhalational Isoflurane Market witnessing a CAGR of 4.2% during the forecast period 2024-2030.

What is the Inhalational Isoflurane Market size in 2030?

Ans: The Inhalational Isoflurane Market size in 2030 will be US$ 26.8 million.

Who are the main players in the Inhalational Isoflurane Market report?

Ans: The main players in the Inhalational Isoflurane Market are KALBE PHARMA, Baxter, Neon Laboratories, AbbVie, Piramal, LAB UNKNOWN, Viatris, PT Novell Pharmaceutical, Sedana Medical, Lunan Beite

What are the Application segmentation covered in the Inhalational Isoflurane Market report?

Ans: The Applications covered in the Inhalational Isoflurane Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Inhalational Isoflurane Market report?

Ans: The Types covered in the Inhalational Isoflurane Market report are Generic Drugs, Brand Drug

Recommended Reports

Inhalational Anesthetics

General Anesthesia

Dental & Local Anesthetics

1 Inhalational Isoflurane Market Overview

1.1 Product Definition

1.2 Inhalational Isoflurane by Type

1.2.1 Global Inhalational Isoflurane Market Value Comparison by Type (2024-2030)

1.2.2 Generic Drugs

1.2.3 Brand Drug

1.3 Inhalational Isoflurane by Application

1.3.1 Global Inhalational Isoflurane Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Inhalational Isoflurane Market Size Estimates and Forecasts

1.4.1 Global Inhalational Isoflurane Revenue 2019-2030

1.4.2 Global Inhalational Isoflurane Sales 2019-2030

1.4.3 Global Inhalational Isoflurane Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Inhalational Isoflurane Market Competition by Manufacturers

2.1 Global Inhalational Isoflurane Sales Market Share by Manufacturers (2019-2024)

2.2 Global Inhalational Isoflurane Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Inhalational Isoflurane Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Inhalational Isoflurane, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Inhalational Isoflurane, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Inhalational Isoflurane, Product Type & Application

2.7 Global Key Manufacturers of Inhalational Isoflurane, Date of Enter into This Industry

2.8 Global Inhalational Isoflurane Market Competitive Situation and Trends

2.8.1 Global Inhalational Isoflurane Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Inhalational Isoflurane Players Market Share by Revenue

2.8.3 Global Inhalational Isoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Inhalational Isoflurane Market Scenario by Region

3.1 Global Inhalational Isoflurane Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Inhalational Isoflurane Sales by Region: 2019-2030

3.2.1 Global Inhalational Isoflurane Sales by Region: 2019-2024

3.2.2 Global Inhalational Isoflurane Sales by Region: 2025-2030

3.3 Global Inhalational Isoflurane Revenue by Region: 2019-2030

3.3.1 Global Inhalational Isoflurane Revenue by Region: 2019-2024

3.3.2 Global Inhalational Isoflurane Revenue by Region: 2025-2030

3.4 North America Inhalational Isoflurane Market Facts & Figures by Country

3.4.1 North America Inhalational Isoflurane Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Inhalational Isoflurane Sales by Country (2019-2030)

3.4.3 North America Inhalational Isoflurane Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Inhalational Isoflurane Market Facts & Figures by Country

3.5.1 Europe Inhalational Isoflurane Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Inhalational Isoflurane Sales by Country (2019-2030)

3.5.3 Europe Inhalational Isoflurane Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Inhalational Isoflurane Market Facts & Figures by Region

3.6.1 Asia Pacific Inhalational Isoflurane Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Inhalational Isoflurane Sales by Region (2019-2030)

3.6.3 Asia Pacific Inhalational Isoflurane Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Inhalational Isoflurane Market Facts & Figures by Country

3.7.1 Latin America Inhalational Isoflurane Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Inhalational Isoflurane Sales by Country (2019-2030)

3.7.3 Latin America Inhalational Isoflurane Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Inhalational Isoflurane Market Facts & Figures by Country

3.8.1 Middle East and Africa Inhalational Isoflurane Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Inhalational Isoflurane Sales by Country (2019-2030)

3.8.3 Middle East and Africa Inhalational Isoflurane Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Inhalational Isoflurane Sales by Type (2019-2030)

4.1.1 Global Inhalational Isoflurane Sales by Type (2019-2024)

4.1.2 Global Inhalational Isoflurane Sales by Type (2025-2030)

4.1.3 Global Inhalational Isoflurane Sales Market Share by Type (2019-2030)

4.2 Global Inhalational Isoflurane Revenue by Type (2019-2030)

4.2.1 Global Inhalational Isoflurane Revenue by Type (2019-2024)

4.2.2 Global Inhalational Isoflurane Revenue by Type (2025-2030)

4.2.3 Global Inhalational Isoflurane Revenue Market Share by Type (2019-2030)

4.3 Global Inhalational Isoflurane Price by Type (2019-2030)

5 Segment by Application

5.1 Global Inhalational Isoflurane Sales by Application (2019-2030)

5.1.1 Global Inhalational Isoflurane Sales by Application (2019-2024)

5.1.2 Global Inhalational Isoflurane Sales by Application (2025-2030)

5.1.3 Global Inhalational Isoflurane Sales Market Share by Application (2019-2030)

5.2 Global Inhalational Isoflurane Revenue by Application (2019-2030)

5.2.1 Global Inhalational Isoflurane Revenue by Application (2019-2024)

5.2.2 Global Inhalational Isoflurane Revenue by Application (2025-2030)

5.2.3 Global Inhalational Isoflurane Revenue Market Share by Application (2019-2030)

5.3 Global Inhalational Isoflurane Price by Application (2019-2030)

6 Key Companies Profiled

6.1 KALBE PHARMA

6.1.1 KALBE PHARMA Company Information

6.1.2 KALBE PHARMA Description and Business Overview

6.1.3 KALBE PHARMA Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.1.4 KALBE PHARMA Inhalational Isoflurane Product Portfolio

6.1.5 KALBE PHARMA Recent Developments/Updates

6.2 Baxter

6.2.1 Baxter Company Information

6.2.2 Baxter Description and Business Overview

6.2.3 Baxter Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Baxter Inhalational Isoflurane Product Portfolio

6.2.5 Baxter Recent Developments/Updates

6.3 Neon Laboratories

6.3.1 Neon Laboratories Company Information

6.3.2 Neon Laboratories Description and Business Overview

6.3.3 Neon Laboratories Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Neon Laboratories Inhalational Isoflurane Product Portfolio

6.3.5 Neon Laboratories Recent Developments/Updates

6.4 AbbVie

6.4.1 AbbVie Company Information

6.4.2 AbbVie Description and Business Overview

6.4.3 AbbVie Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.4.4 AbbVie Inhalational Isoflurane Product Portfolio

6.4.5 AbbVie Recent Developments/Updates

6.5 Piramal

6.5.1 Piramal Company Information

6.5.2 Piramal Description and Business Overview

6.5.3 Piramal Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Piramal Inhalational Isoflurane Product Portfolio

6.5.5 Piramal Recent Developments/Updates

6.6 LAB UNKNOWN

6.6.1 LAB UNKNOWN Company Information

6.6.2 LAB UNKNOWN Description and Business Overview

6.6.3 LAB UNKNOWN Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.6.4 LAB UNKNOWN Inhalational Isoflurane Product Portfolio

6.6.5 LAB UNKNOWN Recent Developments/Updates

6.7 Viatris

6.7.1 Viatris Company Information

6.7.2 Viatris Description and Business Overview

6.7.3 Viatris Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Viatris Inhalational Isoflurane Product Portfolio

6.7.5 Viatris Recent Developments/Updates

6.8 PT Novell Pharmaceutical

6.8.1 PT Novell Pharmaceutical Company Information

6.8.2 PT Novell Pharmaceutical Description and Business Overview

6.8.3 PT Novell Pharmaceutical Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.8.4 PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolio

6.8.5 PT Novell Pharmaceutical Recent Developments/Updates

6.9 Sedana Medical

6.9.1 Sedana Medical Company Information

6.9.2 Sedana Medical Description and Business Overview

6.9.3 Sedana Medical Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Sedana Medical Inhalational Isoflurane Product Portfolio

6.9.5 Sedana Medical Recent Developments/Updates

6.10 Lunan Beite

6.10.1 Lunan Beite Company Information

6.10.2 Lunan Beite Description and Business Overview

6.10.3 Lunan Beite Inhalational Isoflurane Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Lunan Beite Inhalational Isoflurane Product Portfolio

6.10.5 Lunan Beite Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Inhalational Isoflurane Industry Chain Analysis

7.2 Inhalational Isoflurane Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Inhalational Isoflurane Production Mode & Process

7.4 Inhalational Isoflurane Sales and Marketing

7.4.1 Inhalational Isoflurane Sales Channels

7.4.2 Inhalational Isoflurane Distributors

7.5 Inhalational Isoflurane Customers

8 Inhalational Isoflurane Market Dynamics

8.1 Inhalational Isoflurane Industry Trends

8.2 Inhalational Isoflurane Market Drivers

8.3 Inhalational Isoflurane Market Challenges

8.4 Inhalational Isoflurane Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

KALBE PHARMA

Baxter

Neon Laboratories

AbbVie

Piramal

LAB UNKNOWN

Viatris

PT Novell Pharmaceutical

Sedana Medical

Lunan Beite

List of Tables

Table 1. Global Inhalational Isoflurane Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Inhalational Isoflurane Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Inhalational Isoflurane Market Competitive Situation by Manufacturers in 2023

Table 4. Global Inhalational Isoflurane Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Inhalational Isoflurane Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Inhalational Isoflurane Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Inhalational Isoflurane Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Inhalational Isoflurane Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Inhalational Isoflurane, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Inhalational Isoflurane, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Inhalational Isoflurane, Product Type & Application

Table 12. Global Key Manufacturers of Inhalational Isoflurane, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Inhalational Isoflurane by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalational Isoflurane as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Inhalational Isoflurane Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Inhalational Isoflurane Sales by Region (2019-2024) & (K Units)

Table 18. Global Inhalational Isoflurane Sales Market Share by Region (2019-2024)

Table 19. Global Inhalational Isoflurane Sales by Region (2025-2030) & (K Units)

Table 20. Global Inhalational Isoflurane Sales Market Share by Region (2025-2030)

Table 21. Global Inhalational Isoflurane Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Inhalational Isoflurane Revenue Market Share by Region (2019-2024)

Table 23. Global Inhalational Isoflurane Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Inhalational Isoflurane Revenue Market Share by Region (2025-2030)

Table 25. North America Inhalational Isoflurane Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)

Table 27. North America Inhalational Isoflurane Sales by Country (2025-2030) & (K Units)

Table 28. North America Inhalational Isoflurane Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Inhalational Isoflurane Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Inhalational Isoflurane Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)

Table 32. Europe Inhalational Isoflurane Sales by Country (2025-2030) & (K Units)

Table 33. Europe Inhalational Isoflurane Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Inhalational Isoflurane Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Inhalational Isoflurane Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Inhalational Isoflurane Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Inhalational Isoflurane Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Inhalational Isoflurane Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Inhalational Isoflurane Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Inhalational Isoflurane Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Inhalational Isoflurane Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Inhalational Isoflurane Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Inhalational Isoflurane Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Inhalational Isoflurane Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Inhalational Isoflurane Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Inhalational Isoflurane Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Inhalational Isoflurane Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Inhalational Isoflurane Sales (K Units) by Type (2019-2024)

Table 51. Global Inhalational Isoflurane Sales (K Units) by Type (2025-2030)

Table 52. Global Inhalational Isoflurane Sales Market Share by Type (2019-2024)

Table 53. Global Inhalational Isoflurane Sales Market Share by Type (2025-2030)

Table 54. Global Inhalational Isoflurane Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Inhalational Isoflurane Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Inhalational Isoflurane Revenue Market Share by Type (2019-2024)

Table 57. Global Inhalational Isoflurane Revenue Market Share by Type (2025-2030)

Table 58. Global Inhalational Isoflurane Price (US$/Unit) by Type (2019-2024)

Table 59. Global Inhalational Isoflurane Price (US$/Unit) by Type (2025-2030)

Table 60. Global Inhalational Isoflurane Sales (K Units) by Application (2019-2024)

Table 61. Global Inhalational Isoflurane Sales (K Units) by Application (2025-2030)

Table 62. Global Inhalational Isoflurane Sales Market Share by Application (2019-2024)

Table 63. Global Inhalational Isoflurane Sales Market Share by Application (2025-2030)

Table 64. Global Inhalational Isoflurane Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Inhalational Isoflurane Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Inhalational Isoflurane Revenue Market Share by Application (2019-2024)

Table 67. Global Inhalational Isoflurane Revenue Market Share by Application (2025-2030)

Table 68. Global Inhalational Isoflurane Price (US$/Unit) by Application (2019-2024)

Table 69. Global Inhalational Isoflurane Price (US$/Unit) by Application (2025-2030)

Table 70. KALBE PHARMA Company Information

Table 71. KALBE PHARMA Description and Business Overview

Table 72. KALBE PHARMA Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. KALBE PHARMA Inhalational Isoflurane Product

Table 74. KALBE PHARMA Recent Developments/Updates

Table 75. Baxter Company Information

Table 76. Baxter Description and Business Overview

Table 77. Baxter Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Baxter Inhalational Isoflurane Product

Table 79. Baxter Recent Developments/Updates

Table 80. Neon Laboratories Company Information

Table 81. Neon Laboratories Description and Business Overview

Table 82. Neon Laboratories Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Neon Laboratories Inhalational Isoflurane Product

Table 84. Neon Laboratories Recent Developments/Updates

Table 85. AbbVie Company Information

Table 86. AbbVie Description and Business Overview

Table 87. AbbVie Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. AbbVie Inhalational Isoflurane Product

Table 89. AbbVie Recent Developments/Updates

Table 90. Piramal Company Information

Table 91. Piramal Description and Business Overview

Table 92. Piramal Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Piramal Inhalational Isoflurane Product

Table 94. Piramal Recent Developments/Updates

Table 95. LAB UNKNOWN Company Information

Table 96. LAB UNKNOWN Description and Business Overview

Table 97. LAB UNKNOWN Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. LAB UNKNOWN Inhalational Isoflurane Product

Table 99. LAB UNKNOWN Recent Developments/Updates

Table 100. Viatris Company Information

Table 101. Viatris Description and Business Overview

Table 102. Viatris Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Viatris Inhalational Isoflurane Product

Table 104. Viatris Recent Developments/Updates

Table 105. PT Novell Pharmaceutical Company Information

Table 106. PT Novell Pharmaceutical Description and Business Overview

Table 107. PT Novell Pharmaceutical Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. PT Novell Pharmaceutical Inhalational Isoflurane Product

Table 109. PT Novell Pharmaceutical Recent Developments/Updates

Table 110. Sedana Medical Company Information

Table 111. Sedana Medical Description and Business Overview

Table 112. Sedana Medical Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Sedana Medical Inhalational Isoflurane Product

Table 114. Sedana Medical Recent Developments/Updates

Table 115. Lunan Beite Company Information

Table 116. Lunan Beite Description and Business Overview

Table 117. Lunan Beite Inhalational Isoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Lunan Beite Inhalational Isoflurane Product

Table 119. Lunan Beite Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Inhalational Isoflurane Distributors List

Table 123. Inhalational Isoflurane Customers List

Table 124. Inhalational Isoflurane Market Trends

Table 125. Inhalational Isoflurane Market Drivers

Table 126. Inhalational Isoflurane Market Challenges

Table 127. Inhalational Isoflurane Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Inhalational Isoflurane

Figure 2. Global Inhalational Isoflurane Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Inhalational Isoflurane Market Share by Type: 2023 & 2030

Figure 4. Generic Drugs Product Picture

Figure 5. Brand Drug Product Picture

Figure 6. Global Inhalational Isoflurane Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Inhalational Isoflurane Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Other

Figure 11. Global Inhalational Isoflurane Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Inhalational Isoflurane Market Size (2019-2030) & (US$ Million)

Figure 13. Global Inhalational Isoflurane Sales (2019-2030) & (K Units)

Figure 14. Global Inhalational Isoflurane Average Price (US$/Unit) & (2019-2030)

Figure 15. Inhalational Isoflurane Report Years Considered

Figure 16. Inhalational Isoflurane Sales Share by Manufacturers in 2023

Figure 17. Global Inhalational Isoflurane Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Inhalational Isoflurane Players: Market Share by Revenue in Inhalational Isoflurane in 2023

Figure 19. Inhalational Isoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Inhalational Isoflurane Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Inhalational Isoflurane Sales Market Share by Country (2019-2030)

Figure 22. North America Inhalational Isoflurane Revenue Market Share by Country (2019-2030)

Figure 23. United States Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Inhalational Isoflurane Sales Market Share by Country (2019-2030)

Figure 26. Europe Inhalational Isoflurane Revenue Market Share by Country (2019-2030)

Figure 27. Germany Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Inhalational Isoflurane Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Inhalational Isoflurane Revenue Market Share by Region (2019-2030)

Figure 34. China Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Inhalational Isoflurane Sales Market Share by Country (2019-2030)

Figure 42. Mexico Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Inhalational Isoflurane Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Inhalational Isoflurane Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Inhalational Isoflurane Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Inhalational Isoflurane by Type (2019-2030)

Figure 52. Global Revenue Market Share of Inhalational Isoflurane by Type (2019-2030)

Figure 53. Global Inhalational Isoflurane Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Inhalational Isoflurane by Application (2019-2030)

Figure 55. Global Revenue Market Share of Inhalational Isoflurane by Application (2019-2030)

Figure 56. Global Inhalational Isoflurane Price (US$/Unit) by Application (2019-2030)

Figure 57. Inhalational Isoflurane Value Chain

Figure 58. Inhalational Isoflurane Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Inhalation Anesthesia Drugs Market Research Report 2024

Global Inhalation General Anesthesia Drugs Market Research Report 2024

Inhalation Sevoflurane Anaesthetic Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sevoflurane For Inhalation Market Research Report 2024

Global Inhalational Anaesthesia Drugs Market Research Report 2024

Global Inhalation Sevoflurane Anesthesia Drugs Market Research Report 2024

Global Desflurane Market Research Report 2024

Global Isoflurane Market Insights Forecast to 2030

Global Sevoflurane Anesthesia Drugs Market Research Report 2024

Global Medical Sevoflurane Market Research Report 2024

Global Inhalational Anesthetic Market Research Report 2024

Global Sevoflurane Market Research Report 2024

Global Sevoflurane Sevoflurane Source Market Research Report 2024

Global Inhalational Anesthesia Drugs Market Research Report 2024

Global Anesthesia Gas Market Research Report 2024

Global Halogenated Hydrocarbon General Anesthetics Market Research Report 2024

Global Sevoflurane Source Market Insights Forecast to 2030

Global Inhalation Sedatives Market Research Report 2024

Global Isoflurane Anesthesia Vaporizers Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions